Efficacy and safety of ublituximab for relapsing multiple sclerosis patients: current evidence and expert opinion. Preziosa P, Brescia Morra V, Capobianco M, Gasperini C, et al. J Neurol 2025;272:707.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Preziosa P, Brescia Morra V, Capobianco M, Gasperini C, et al. Efficacy and safety of ublituximab for relapsing multiple sclerosis patients: current evidence and expert opinion. J Neurol 2025;272:707.
PMID: 41107611